Sci Simple

New Science Research Articles Everyday

# Health Sciences # Ophthalmology

The Silent Threat of Diabetic Retinopathy

Raising awareness of diabetic retinopathy's risks and the importance of regular eye care.

Emmanuel Appiagyei, Yaw Akye Essuman, Akwasi Agyeman Ahmed

― 5 min read


Diabetic Retinopathy Diabetic Retinopathy Awareness drastically affect vision. Eye health matters; diabetes can
Table of Contents

Diabetic retinopathy (DR) is a serious eye condition that affects people with diabetes. It is one of the major complications related to diabetes and is a leading cause of vision loss, especially among people of working age in developing countries. The problem arises from changes in the blood vessels of the retina, which is the light-sensitive layer at the back of the eye. When these blood vessels become damaged, it can lead to various stages of retinopathy, which can impair vision.

How is Diabetic Retinopathy Diagnosed?

Healthcare providers diagnose diabetic retinopathy by examining the retina for signs of blood vessel issues. There are two main stages of diabetic retinopathy:

  1. Non-Proliferative Diabetic Retinopathy (NPDR): This stage is when blood vessels may swell or leak fluid, leading to small areas of bleeding in the retina.
  2. Proliferative Diabetic Retinopathy (PDR): This more advanced stage occurs when new, fragile blood vessels grow. These vessels can bleed into the eye, causing significant problems like blurry vision or even blindness.

To put it simply, NPDR is like having a flat tire that needs air, while PDR is like driving with a flat tire that’s about to blow.

The Scope of the Problem

Globally, the number of people diagnosed with diabetes is expected to rise dramatically. From around 366 million people in 2011, estimates suggest it could grow to 552 million by 2030. A significant portion of this group is middle-aged, making the risk of diabetic retinopathy particularly concerning.

About 34.6% of people with diabetes are found to have some level of diabetic retinopathy. In specific regions like Ghana and Nigeria, studies show rates between 15.5% and 17%. This means that quite a few folks are at risk of losing their sight due to this condition.

Who is at Risk?

Several factors contribute to the development and worsening of diabetic retinopathy. These include:

  • Long-term Diabetes: The longer you have diabetes, the higher your risk.
  • Poor Blood Sugar Control: High glucose levels can damage blood vessels over time.
  • High Blood Pressure: Hypertension can worsen the condition.
  • Cholesterol Issues: Having unhealthy cholesterol levels can also play a role.
  • Kidney Disease: This can increase the likelihood of developing diabetic retinopathy.
  • Gender: Some studies suggest that women might be at higher risk.

The Impact of Diabetic Retinopathy

Visual impairment caused by diabetic retinopathy not only affects vision but also significantly impacts a person's quality of life. When vision deteriorates, it can complicate diabetes management, leading to a vicious cycle of worsening health. People might find it harder to monitor their blood sugar levels or adhere to treatment plans.

Surprisingly, many individuals with diabetes are aware that their condition can affect their eyesight but still do not seek regular Eye Care. Barriers to getting screened include:

  • Lack of knowledge about diabetic retinopathy.
  • Fear of what they might learn from tests.
  • Financial constraints related to healthcare costs.
  • Geographic challenges, such as having to travel far for eye care.

The Study

In a recent study conducted at a major eye center, researchers looked into the state of diabetic retinopathy among patients. They focused on patients aged 18 and above who had confirmed diabetes. Those with other eye conditions were excluded to ensure the findings were focused on diabetic retinopathy alone.

Out of 78 participants, the average age was around 50 years. About 83% were covered by a national health insurance scheme, making access to healthcare easier for most. Most participants had at least completed primary education, indicating a relatively informed group.

Knowledge is Power!

The study also measured the participants’ understanding of diabetic retinopathy. On a scale where the highest score was 12, the average knowledge score was just over 5. This shows that a considerable number of participants had poor knowledge about the disease and its risks. Many knew diabetes could affect their eyes, but fewer recognized what diabetic retinopathy was or that it could lead to blindness.

Interestingly, while people in other countries might have a higher awareness of these risks, our study revealed that many patients were not well-informed. This gap in knowledge can have serious consequences for their health.

The Findings

All participants had some form of diabetic retinopathy, with some showing very severe stages of the condition. About 37.2% had advanced PDR, while a few had signs of mild to severe NPDR. When looking at the eyes individually, 88.5% showed signs of retinopathy, highlighting how common this issue is among those with diabetes.

The Reasons for Delays in Seeking Help

Participants shared several reasons for not seeking eye examinations sooner. The lack of knowledge was the most frequently mentioned reason, followed by:

  • Fear of discovering a serious problem.
  • Difficulty accessing eye care.
  • High costs associated with treatment.
  • Transportation challenges to get to eye care facilities.

These reasons are not uncommon and reflect a broader issue in many healthcare systems, particularly in developing regions.

A Call to Action

Given the high rates of diabetic retinopathy among patients and their lack of awareness, there’s an urgent need for better education about this condition. It’s important for people with diabetes to understand the risks and to seek regular eye examinations.

Healthcare providers should also work on making eye care more accessible, particularly in rural areas where eye specialists may be scarce. Regular check-ups could catch issues early on, potentially saving patients from more severe complications down the line.

Closing Thoughts

While diabetic retinopathy is a serious condition, raising awareness and improving education can make a significant difference. If you have diabetes or know someone who does, it’s essential to prioritize eye health. Remember, you can’t manage what you don’t measure, and keeping an eye on your eye health can help you keep your vision for years to come. So, let’s not wait for sight to dim before we act!

Original Source

Title: Diabetic Retinopathy: Knowledge, Staging and Barriers to Early Presentation in a Tertiary Eye Care Centre in Ghana

Abstract: BackgroundDiabetic retinopathy is the most common microvascular complication of diabetes mellitus and a leading cause of new-onset blindness in populations of working age. Late presentation of patients to eye care facilities has been associated with the development of vision-threatening complications. The study sought to determine the clinical profile, knowledge and factors influencing late presentation of diabetic retinopathy among diabetics at the Eye Centre of the Komfo Anokye Teaching Hospital in Ghana. MethodsThis descriptive cross-sectional study was conducted between the periods of February 2022 to April 2022. All diabetic patients referred to the retina clinic were examined for diabetic retinopathy. Both eyes of participants were examined and the eye with the most severe form of diabetic retinopathy was used for the staging. A structured questionnaire was employed to collect patients socio-economic factors and knowledge on diabetic retinopathy. Data was analysed using the SPSS ver. 23 software. Statistical significance was set at p

Authors: Emmanuel Appiagyei, Yaw Akye Essuman, Akwasi Agyeman Ahmed

Last Update: 2024-12-02 00:00:00

Language: English

Source URL: https://www.medrxiv.org/content/10.1101/2024.12.01.24318265

Source PDF: https://www.medrxiv.org/content/10.1101/2024.12.01.24318265.full.pdf

Licence: https://creativecommons.org/licenses/by/4.0/

Changes: This summary was created with assistance from AI and may have inaccuracies. For accurate information, please refer to the original source documents linked here.

Thank you to medrxiv for use of its open access interoperability.

Similar Articles